Media stories about Kindred Healthcare (NYSE:KND) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Kindred Healthcare earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the health services provider an impact score of 45.6738446669717 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

Several research firms have weighed in on KND. BidaskClub downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Deutsche Bank AG dropped their price target on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, August 7th. Royal Bank Of Canada reissued a “sector perform” rating and set a $8.50 price target (up previously from $7.50) on shares of Kindred Healthcare in a research report on Thursday, November 9th. ValuEngine raised Kindred Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, November 9th. Finally, Zacks Investment Research downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a research report on Wednesday, August 30th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $9.17.

Kindred Healthcare (KND) traded down $0.10 during mid-day trading on Friday, hitting $7.60. The stock had a trading volume of 709,550 shares, compared to its average volume of 1,280,000. Kindred Healthcare has a 1-year low of $5.50 and a 1-year high of $11.90. The firm has a market capitalization of $652.11, a PE ratio of 38.00 and a beta of 1.11. The company has a quick ratio of 1.53, a current ratio of 1.55 and a debt-to-equity ratio of 6.22.

Kindred Healthcare (NYSE:KND) last issued its earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.08. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter last year, the firm earned $0.05 earnings per share. The firm’s revenue for the quarter was down 5.5% compared to the same quarter last year. sell-side analysts forecast that Kindred Healthcare will post 0.29 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/18/kindred-healthcare-knd-earns-daily-news-sentiment-rating-of-0-14.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Insider Buying and Selling by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.